Financial Performance

Biotech firm ProMIS Neurosciences reveals novel vaccine data for ALS and Parkinson's, using a platform that selectively targets only toxic proteins.

New data suggests Phanes Therapeutics' bispecific antibody may overcome major side effects of CD47 inhibitors while showing promise in tough GI cancers.

NJMEP secures a new five-year NIST contract to help manufacturers tackle workforce, tech, and supply chain challenges, reaffirming a 30-year partnership.

As a federal shutdown enters its second month, a Gulf Coast credit union is deploying teams to airports to provide no-fee paycheck advances to TSA workers.

Mayfair High's new immersive lab promises a new era of career training, but it also highlights the high-stakes gamble of educational technology.

A new deal between Arcana Collective and Neptune Seed Bank brings revered legacy cannabis genetics to a massive global audience of home growers.

With veteran leader Brian McKelligon at the helm, Infinity Bio aims to commercialize its powerful MIPSA platform and redefine precision medicine.

The fitness app's latest partnership signals a major pivot, embracing creative experiences as the new frontier of holistic well-being and the experience economy.

As fuel costs sway travel plans, RVshare offers up to $1M in gas rebates, making spring and summer road trips a more affordable and appealing option.

The real estate trust is selling a Québec asset to fund a major acquisition near Edmonton, signaling a decisive pivot towards Western Canada's industrial core.

Entering its 12th year, this award-winning business podcast remains a vital resource for CEOs, translating expert insights into actionable growth strategies.

A new report shows Washington charter school alumni earn more and own homes at higher rates, but small sample sizes spark a debate on the data's weight.

As AI-driven attacks rise, Corelight's new agentic AI suite promises to speed up defense with a key differentiator: full, defensible transparency.

With a new hire from Bain, Inveniam is building an AI and blockchain-powered system to solve private market illiquidity. Here's how it works.

A new partnership seeks to conquer C. difficile, a deadly hospital infection that has stumped pharma giants, by advancing a novel dual-action vaccine.

The strategic divestment to Blue Moon Metals highlights Liberty Gold's pivot to its core gold assets and a broader mining trend of portfolio specialization.

A new collaboration will use innovative protein binders to fight animal disease, bolstering global food security and public health under the One Health framework.

ASM's flagship case competition reveals a pivotal shift in business strategy, emphasizing ESG integration, holistic thinking, and AI-driven future leadership.

As the EU AI Act's 2026 deadline looms, DEKRA becomes the first gatekeeper for high-risk biometric systems, a move shaping the future of AI trust.

INVL Asset Management launches a new fund, lowering the entry barrier to Europe's booming B2B software market through a partnership with Main Capital Partners.